Trial Details
COMPLETEDBasic Information
| Clinical ID | c2276 |
|---|---|
| Identifier | NCT03752970 |
| Trial Title | A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Spesolimab|DRUG: Placebo |
Participant Information
| Sponsor | Boehringer Ingelheim |
|---|---|
| City | Vienna |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-02-05 |
|---|---|
| Primary Completion Date | 2021-12-01 |
| Completion Date | 2022-07-04 |